ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001

SWOG Wins Funding For H. Pylori Trial.

November 21, 2008

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer

November 26, 2010

ONS Opposes AMA On “Registered Care Technologist”

August 19, 1988

In Brief: ONS Lectures Announced; Brennan To Retire As Michigan Cancer Foundation President

April 19, 1991